BRD7 and nasopharyngeal carcinoma: In our laboratory, BRD7 has been reported as absent or expressed at unusually low levels in nasopharyngeal carcinoma (NPC) biopsies, and overexpression of BRD7 inhibits NPC cell growth and arrest cells in the G0/G1 phase of the cell cycle[18].